Premium
P3‐254: SERUM GALECTIN‐3 LEVEL IS ASSOCIATED WITH COGNITIVE DECLINE IN ALZHEIMER'S DISEASE PATIENTS
Author(s) -
Fuh Jong-Ling,
Lee Wei-Ju,
Liao Yi-Chu,
Wang Shuu-Jiun
Publication year - 2018
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2018.06.1614
Subject(s) - clinical dementia rating , medicine , apolipoprotein e , dementia , disease , neuropsychology , gastroenterology , cognition , oncology , psychiatry
Figure 1. Mor tau particles in FORMATION PROPENSITY: ALZHEIMER’S DISEASE BIOMARKER igure 2. Enhanced binding of Ab-42 or tau peptides with purified VLDL nd LDL particles. Shanmugavel Madasamy, Jason Lundry, Angela Abrea, Shreya Mathur, Sundar Shanmugavel, Raymond Kong, Ben Alderete, J. Paul Robinson, Ravikumar Ponnusamy, Ahmad Salehi, Elliott J. Mufson, Alan Wu, Plaxgen Inc, Fremont, CA, USA; Millipore Sigma, Seattle, WA, USA; Cytometry Laboratories, West Lafayette, IN, USA; Barrow Neurological Institute, Phoenix, AZ, USA; University of California, San Francisco, CA, USA. Contact e-mail: shan@ plaxgen.com